Search This Blog

Friday, December 15, 2023

US FDA approves Astellas' combination therapy for bladder cancer

 The U.S. Food and Drug Administration on Friday approved Astellas Pharma's drug in combination with Merck's Keytruda for a type of bladder cancer.

https://finance.yahoo.com/news/us-fda-approves-astellas-combination-204745724.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.